Thrivent Financial for Lutherans Has $5.73 Million Stake in CVS Health Co. (NYSE:CVS)

Thrivent Financial for Lutherans lessened its position in CVS Health Co. (NYSE:CVS - Free Report) by 26.3% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 91,055 shares of the pharmacy operator's stock after selling 32,496 shares during the period. Thrivent Financial for Lutherans' holdings in CVS Health were worth $5,726,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of CVS. Garland Capital Management Inc. lifted its position in shares of CVS Health by 0.3% during the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator's stock valued at $3,591,000 after acquiring an additional 160 shares during the last quarter. Sound Income Strategies LLC lifted its holdings in shares of CVS Health by 7.2% during the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock valued at $151,000 after purchasing an additional 162 shares during the last quarter. Plimoth Trust Co. LLC boosted its position in shares of CVS Health by 0.4% in the 2nd quarter. Plimoth Trust Co. LLC now owns 46,637 shares of the pharmacy operator's stock valued at $2,754,000 after purchasing an additional 174 shares during the period. Hexagon Capital Partners LLC increased its stake in CVS Health by 3.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator's stock worth $331,000 after purchasing an additional 178 shares in the last quarter. Finally, Pallas Capital Advisors LLC raised its holdings in CVS Health by 2.5% during the 2nd quarter. Pallas Capital Advisors LLC now owns 7,458 shares of the pharmacy operator's stock worth $447,000 after buying an additional 183 shares during the period. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Up 1.6 %

CVS Health stock traded up $0.91 during mid-day trading on Friday, hitting $58.01. 11,153,900 shares of the company's stock were exchanged, compared to its average volume of 12,620,673. CVS Health Co. has a 1-year low of $52.71 and a 1-year high of $83.25. The stock has a 50 day moving average of $59.21 and a two-hundred day moving average of $58.63. The stock has a market cap of $73.00 billion, a P/E ratio of 14.72, a P/E/G ratio of 0.96 and a beta of 0.55. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same period in the previous year, the company earned $2.21 EPS. The company's revenue for the quarter was up 6.3% on a year-over-year basis. As a group, analysts anticipate that CVS Health Co. will post 5.43 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.59%. The ex-dividend date was Monday, October 21st. CVS Health's dividend payout ratio is currently 67.51%.

Wall Street Analyst Weigh In

CVS has been the topic of several analyst reports. UBS Group lifted their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a research report on Thursday, November 7th. Cantor Fitzgerald reissued a "neutral" rating and set a $62.00 target price on shares of CVS Health in a research note on Tuesday, October 1st. Evercore ISI raised their target price on CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 8th. Wells Fargo & Company raised CVS Health from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Finally, Barclays decreased their price objective on CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a research report on Thursday, November 7th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $72.28.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.